title: Treatment of cutaneous leishmaniasis with nitric-oxide donor.
authors.forename: P
authors.initials: P
authors.lastname: López-Jaramillo
authors.forename: C
authors.initials: C
authors.lastname: Ruano
authors.forename: J
authors.initials: J
authors.lastname: Rivera
authors.forename: E
authors.initials: E
authors.lastname: Terán
authors.forename: R
authors.initials: R
authors.lastname: Salazar-Irigoyen
authors.forename: J V
authors.initials: JV
authors.lastname: Esplugues
authors.forename: S
authors.initials: S
authors.lastname: Moncada
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007892:Leishmania braziliensis / Q000187:drug effects*; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009569:Nitric Oxide / Q000502:physiology; D010396:Penicillamine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: C110881:S-nitro-N-acetylpenicillamine; D009569:Nitric Oxide; D010396:Penicillamine